Skip to Content
Merck
CN
  • Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.

Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.

Natural product reports (2013-09-24)
Sumit Bansal, Sandeep Vyas, Shoumyo Bhattacharya, Manu Sharma
ABSTRACT

Extensive research on tea catechins, mainly (-)-epigallocatechin gallate, has shown numerous health promoting effects. However, various clinical studies demonstrated several issues associated with tea catechins which account for their poor systemic bioavailability. In order to improve pharmacological activity and bioavailability of natural tea catechins, two major strategies have been adopted to date which include synthesizing catechin analogs/prodrugs and the development of novel drug delivery systems. In this review, we provide a detailed account of novel synthetic analogs/prodrugs as well as novel drug delivery approaches used for natural tea catechins to make them therapeutically potent drug-like molecules.

MATERIALS
Product Number
Brand
Product Description

Supelco
(−)-Epicatechin, analytical standard
Sigma-Aldrich
(−)-Epicatechin, ≥98% (HPLC), from green tea
Sigma-Aldrich
(−)-Epicatechin, ≥90% (HPLC)
Epicatechin, primary reference standard
Supelco
(+)-Catechin, analytical standard
Epigallocatechin gallate, primary reference standard
Supelco
(−)-Epigallocatechin gallate, analytical standard
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥95%
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥80% (HPLC), from green tea